The Protective Effect of Mask Wearing Against Respiratory Tract Infections

NCT05690516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4575

Last updated 2023-11-29

No results posted yet for this study

Summary

In this trial the researchers plan to recruit 4,000 volunteers to be randomly allocated either wearing face masks in public spaces where they are close to other people, or not wear face masks in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about whether they experienced the common cold, influenzas or COVID-19 symptoms during the trail period.

Conditions

Interventions

BEHAVIORAL

Wearing face masks

Participants are asked to wear face masks in public spaces.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER
  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Runar Solberg, PhD · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2023-05-01
Completion
2023-05-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05690516 on ClinicalTrials.gov